Owen Mumford appoints Mark Glass as director of pharmaceutical services

Appointment strengthens Owen Mumford’s pharmaceutical services leadership team

Owen Mumford, a globally recognised innovator in medical device development and manufacturing, has announced the appointment of Mark Glass as director of pharmaceutical services.

With a strong scientific background and over 20 years of experience in the pharmaceutical sector, Mark has delivered innovative solutions to drug developers across the globe. His career spans the full product lifecycle, from clinical development through to commercialisation, navigating complex regulatory environments. He has worked with a diverse range of customers, from single-product innovators to multinational pharmaceutical giants, equipping him with the insight and agility to foster long-term, mutually beneficial partnerships.

Prior to joining Owen Mumford, Mark was head of business development EU, health sciences, drug development at SGS. He also held senior roles at Catalent Pharma Solutions, Eurofins, and Thermo Fisher Scientific, bringing a wealth of commercial and strategic expertise to his new role.

“We’re excited to have Mark on board,” said Gavin Jones, managing director at Owen Mumford. “His background and experience make him a valuable addition to both the pharmaceutical services team and the executive team. His input will strengthen these groups, helping to advance strategies aimed at growing pharmaceutical services and the wider business.”

Commenting on his appointment, Mark said: “Owen Mumford has been a trusted name in our industry for decades, with a proven reputation for innovation and quality. I’m excited to be joining the business at such a pivotal time, as we continue to launch new technologies in an ever-evolving market. I’m fortunate to be surrounded by a strong and collaborative team here that already champions a culture of positivity, teamwork, and accountability. My aim is to build on this solid foundation by driving continuous improvement and ensuring our commercial operations reflect the same ambition and rigour as our R&D and operations teams.”

Will you be at the PDA conference on 21–22 October? Meet Mark and the Owen Mumford pharmaceutical services team at booth #100/#101. You can also find Mark on LinkedIn.

You may also like